






Ototoxicity is a preventable cause of
irreversible sensorineural hearing loss. This paper aims to
highlight the pattern of ototoxicity seen in a tertiary health
institution.
A retrospective study of patients with ototoxicity
seen over a seven year period at ENT department of
Aminu Kano Teaching Hospital, Kano. Case notes were
retrieved and studied.
Fifty nine patients made up 37 males and 22
females were seen with 86% in the age group 20-60years.
The commonest ototoxic drugs were aminoglycosides
(37.3%), loop diuretics (27.1%), antimalarials (23.7%)
and traditional concoctions (11.9%). The commonest
presentation from most drugs was permanent
sensorineural hearing loss (50-85%). Associated co-
morbid conditions included “febrile illness” (47.5%),
hypertension (30.5%), diabetes mellitus (13.6%), renal
disease (5%). Follow-up was poor. Only 18 patients
presented for review beyond a second hospital visit, only
those with ototoxicity from antimalarials recovered
hearing. There were no effective audiometric and serum
drug monitoring mechanism in place before, during or
after therapy with ototoxic medications.
Ototoxicity is not uncommon and attempts
at prevention are feeble. Increased awareness of this
condition is advised. High frequency audiometric
assessment, otoacoustic emission and serum drug
monitoring facilities should be provided at health
institutions. Caution should be exercised when
prescribing ototoxic drugs in the presence of other risk
factors.
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Certain drugs are known to cause damage to inner ear
structures leading to ototoxicity, sometimes this damage
may occur after a single dose of the medication, but more
often it happens after repeated dosing. The onset of
ototoxicity is unpredictable, ranging from immediate
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The consequences of ototoxicity include problems with
language development and learning in children and
decreased socioeconomic activities and decreased
overall quality of life in the adult. No therapy is currently
available for reversal of the hair cell damage of ototoxic
medications and so management emphasis should be
on prevention. This requires an increased awareness of
this condition.
This paper aims to highlight the pattern of ototoxicity
seen in a hospital setting. Knowledge of this will
increase awareness of this condition and reduce the
incidence of ototoxicity.
This is a hospital based retrospective study of 59
patients diagnosed with ototoxicity over a 7 year period
(2001-2008) at the ENT department of Aminu Kano
Teaching Hospital, Kano. Case notes were retrieved
and studied. Information obtained included patients
age, sex, incriminated drug, manifested features of
ototoxicity and audiological findings.Any associated co-
morbid factors were also noted. Data was analyzed by
simple descriptive method.
There were 37 males and 22 females (M1.7: 1F) aged
between 2 years to 71 years with a mean of 41 years.
Eighty six percent of the patients were between the
ages of 20-60years.(Table 1). The most frequent drugs
causing ototoxicity were aminoglycosides- gentamycin
and streptomycin 22 cases (37.3%), loop diuretics-16
cases (27.1%), antimalarials- chloroquine and quinine-
14 cases (23.7%) and traditional concoction-7 cases
(11.9%).
The associated co-morbid conditions included febrile
illness (47.5%), hypertension (30.5%), diabetes mellitus
(13.6%) and renal disease (5%).
manifested as severe
high frequency sensorineural hearing loss (68.2% of
patients), tinnitus (41%) and disturbance of balance
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Loop diuretic ototoxicity
Antimalarial ototoxicity
Ototoxicity from traditional concoction
Table I: Age and sex distribution of patients with
ototoxicity
Discussion
manifested as mild to
moderate high frequency sensorineural hearing loss
(50%), tinnitus (43.8%) and disturbance of balance
(25%). Associated co-morbid factors were hypertension,
diabetes mellitus, renal failure.
manifested as tinnitus (64.3%),
mild to moderate, low to mid frequency sensorineural
hearing loss (57.2%) and balance disturbance (7.2%).
manifested as
low frequency sensorineural hearing loss of varying
severity ranging from mild to severe (85.7%) and tinnitus
(28.6%).
Eighteen cases were available for follow-up, only those
with antimalarial ototoxicity were noted to have recovered
hearing.
The magnitude of ototoxicity worldwide is not accurately
known. Studies have found ototoxicity to account for
about 2-20% of hearing loss in children. In Tanzania,
ototoxicity was noted to be the second most common
cause of deafness. In this study, the bulk of cases were
young and middle aged adults constituting 86% of the
cases. It is probable that cases of ototoxicity in children in
this setting are missed or overlooked or the hearing loss
blamed on some other aetiologic factor.
Aminoglycosides were the most frequent cause of
ototoxicity in this study. The high prevalence of
aminoglycoside ototoxicity in developing countries has
been observed by other authors. This high prevalence
has been blamed on the drug's low cost, availability
without prescription and effectiveness against gram
negative bacteria and mycobacterium. This therapeutic
efficacy has continued to maintain the relevance of
aminoglycosides today despite the risk of ototoxicity. In
the United states for instance, about 4 million courses of
aminoglycosides are administered annually. It is a
common observation in this environment for individuals
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Age(yrs) No.(%) Males Females
<20years 4 (6.8) 2 2
20-40yrs 26(44.1) 18 8
41-60yrs 25(42.3) 14 11
>60yrs 4(6.8) 3 1
It is not clear whether the co-morbid condition of “febrile
illness” which many patients complained of as
necessitating their use of gentamycin contributed to the
prevalence of hearing loss in this study. Such “febrile
illness” included but not limited to viral infection and
bacterial meningitis.
There is an increased susceptibility to aminoglycoside
toxicity in individuals with mutation of the 12S rRNA
gene which is maternally inherited, it is therefore
common to have maternal relatives with similar hearing
deficit after aminoglycoside use. Specific history of
maternal relatives having similar hearing problems was
absent from the records reviewed in this study.
Since other risk factors for aminoglycoside ototoxicity
such as extremes of age or co-administration of other
ototoxic drugs were not evident in this study, it is
probable therefore that aminoglycoside ototoxicity in
this environment may due to genetic susceptibility or
may be dose related.
Sensorineural hearing loss was the commonest
presentation of aminoglycoside ototoxicity in this study.
This is a common finding worldwide. The hearing loss
is usually permanent due to irreversible destruction of
the outer hair cells of the organ of corti particularly those
at the basal turn of cochlea. None of the patients who
turned up for follow up recovered hearing in this study.
Vestibular function is said to be much more sensitive to
aminoglycosides than the cochlea. In the absence of a
hearing loss, vestibular features may be missed as
early warning sign of ototoxicity.
The dosing regime observed in this study were single
large dose of aminoglycosides (which was repeated in
some cases) and prolonged therapy with multiple doses
of aminoglycosides. Studies have shown that if the
same total daily dose is given as once daily regimen
rather than multiple dosing, the drug efficacy was the
same but with decreased risk of ototoxicity.
Loop diuretics used in hypertensive and renal failure
therapy were found to be the next most common group
of ototoxic drugs in this study. High doses given
intravenously are known to cause hearing loss. It is not
clear however, whether the prevalence of ototoxicity in
this subset of patients was influenced by the primary
diseases of renal failure, hypertension or diabetes
mellitus. Lasisi et al reported on 2 patients with renal
failure who developed profound sensorineural hearing
loss after 5-7 sessions of dialysis  . Hypertension and
Diabetes Mellitus can induce angiopathies which may
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Loop diuretics act on the stria vascularis and produce
oedema of these tissues and a temporary loss of function,
resulting in a decrease of the endocochlea potential. The
ototoxicity caused by loop diuretics tend to be reversible
with drug withdrawal. However, this study did not find any
case that recovered hearing completely after withdrawal
of the drug, lending support to the possibility of the
associated co-morbid conditions contributing to the
hearing impairment in these cases.
Kshirsagar et al from their study, concluded that when
frusemide is given slowly and in lower doses, the risk of
ototoxicity is low provided plasma protiens are within
normal limits.
Majority of patients with antimalarial induced ototoxicity
presented with tinnitus and a mild to moderate hearing
loss that recovered after treatment. Tinnitus preceded the
hearing loss in all cases, the onset of tinnitus can therefore
be taken as a warning sign of ototoxicity in those on
antimalarials. Quinine appears to be more cochleotoxic
than chloroquine and from laser doppler flowmetry study,
it appears to cause vasoconstriction and decrease
cochlea blood flow, a mechanism of action similar to that
of acetyl salicylic acid. The current trend of using
alternative non-ototoxic antimalarials will greatly reduce
the incidence of ototoxicity from antimalarials.
Traditional concoction is a commonly employed remedy
for virtually any kind of illness in this environment. Several
cases of ototoxicity have been recorded from its use. In
this study it accounted for nearly 12% of the cases seen. It
is difficult to determine what constitute any particular
concoction as different traditional healers dispense
different concoctions and further, most patients on
traditional concoction are particularly warned not to seek
orthodox attention. This makes it difficult to determine the
magnitude of hearing loss from use of traditional
concoction.
Ototoxicity from such medications as macrolides,
salicylates, non-steroidal antinflammatory drugs, and
anti-neoplastic drugs which featured in several
publications were not seen in this study. It is probable
that deafness resulting from these medications in this
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disease.
It is also difficult to determine ototoxicity from patients
using ototopical medications in this environment as the
primary ear condition is mostly blamed for any resulting
hearing loss. In a survey of otolaryngologists in the
United states, Lundy and Graham reported that 84.1%
of ORL surgeons use ototopical medications in the face
of tympanic membrane perforation, and 3.4% admitted
to have witnessed irreversible inner ear damage from
the drugs.
Auditory assessment of patients in this study utilized
pure tone audiometry (PTA) at the conventional
frequencies (0.25-8KHz), this is unlikely to detect the
earliest signs of ototoxicity which in the case of
aminoglycosides affects frequencies above 8KHz first.
Early cases will therefore be missed if conventional PTA
frequencies are utilized. Distortion product otoacoustic
emission and high frequency auditory testing (9-20KHz)
were found to be most sensitive for detecting early
ototoxicity.
Ototoxicity is a preventable disease, this study
observed that such preventive methods as routine
audiological assessment during drug therapy, serum
drug estimation were unavailable or impracticable due
to low resources. This is probably the situation in other
low resource settings.
Ototoxicity is not uncommon and attempts at preventing
it in this environment is not satisfactory. There is a need
for increased awareness of the effects and
consequencies of ototoxic drugs. These drugs should
be used only when necessary and at minimal effective
dosage.
Health authorities should ensure that facilities for
audiological assessment during ototoxic drug therapy
along with serum drug monitoring facilities are in place.
Risk factors such as co administrations of ototoxic
drugs, exposure to noise within 6 months of ototoxic
medications, renal failure and hypoproteineamic states
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